Universe Pharmaceuticals ... (UPC)
NASDAQ: UPC
· Real-Time Price · USD
3.54
-0.02 (-0.56%)
At close: Aug 15, 2025, 12:12 PM
Universe Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 |
Revenue | 19.29M | 23.02M | 26.73M | 32.31M | 34.41M | 40.14M | 47.89M | 47.98M | 39.64M |
Cost of Revenue | 13.3M | 16.95M | 19.42M | 22.23M | 20.34M | 18.46M | 20.99M | 22.85M | 20.73M |
Gross Profit | 5.99M | 6.07M | 7.31M | 10.08M | 14.07M | 21.69M | 26.9M | 25.14M | 18.92M |
Operating Income | -8.61M | -8.02M | -5.42M | -3.53M | -9.99M | -7.44M | 6.71M | 13.59M | 14.76M |
Interest Income | n/a | n/a | n/a | 166.93K | 166.93K | 696.43K | 935.98K | 239.55K | n/a |
Pretax Income | 1.03M | -8.12M | -16.58M | -3.88M | -11.07M | -8.02M | 7.43M | 13.65M | 14.58M |
Net Income | 1.09M | -8.73M | -18.55M | -6.16M | -11.18M | -8.74M | 5.9M | 11.32M | 10.93M |
Selling & General & Admin | 10.99M | 10.44M | 9.91M | 8.61M | -15.03M | -7.86M | 14.89M | 6.08M | 3.31M |
Research & Development | 3.05M | 3.04M | 2.7M | 4.9M | 9.78M | 7.62M | 5.16M | 5.35M | 612.11K |
Other Expenses | 558.67K | 604.47K | 114.59K | 95.58K | 29.09M | 29.14M | 323.29K | 304.04K | 240.87K |
Operating Expenses | 14.6M | 14.09M | 12.72M | 13.6M | 23.84M | 28.91M | 20.38M | 11.74M | 4.16M |
Interest Expense | 270.3K | 278.17K | 218.83K | 156.79K | 148.58K | 162.4K | 143.32K | 101.6K | 108.55K |
Selling & Marketing Expenses | 7.26M | 7.26M | n/a | n/a | -20.25M | 18.3M | 40.36M | 2.97M | 1.94M |
Cost & Expenses | 27.9M | 31.04M | 32.14M | 35.84M | 43.98M | 47.16M | 41.18M | 34.39M | 24.89M |
Income Tax Expense | -58.44K | 606.7K | 2M | 2.31M | 148.56K | 752.42K | 1.53M | 2.36M | 3.68M |
Shares Outstanding (Basic) | 3.48K | 6.08K | 6.08K | 5.92K | 5.92K | 5.92K | 5.92K | 5.27K | 5.27K |
Shares Outstanding (Diluted) | 3.48K | 6.08K | 6.08K | 5.92K | 5.92K | 5.92K | 5.92K | 5.27K | 5.27K |
EPS (Basic) | -224.61 | -1.44K | -3.08K | -1.04K | -1.89K | -1.48K | 1.08K | 2.15K | 2K |
EPS (Diluted) | -224.61 | -1.44K | -3.08K | -1.04K | -1.89K | -1.48K | 1.08K | 2.15K | 2K |
EBITDA | 1.81M | -7.36M | -15.86M | -3.22M | -10.43M | -7.33M | 8.07M | 14.2M | 15.14M |
EBIT | 1.3M | -7.84M | -16.36M | -3.72M | -10.93M | -7.86M | 7.57M | 13.75M | 14.69M |
Depreciation & Amortization | 506.51K | 485.73K | 499.87K | 508.79K | 499.62K | 533.95K | 495.52K | 446.88K | 448.5K |